Cardiac Wire #257 March 24, 2025
Amvuttra’s Approval | Generic Rivaroxaban
Cardiac Wire #256 March 20, 2025
Amulet’s LAAO Edge | Proteinuria Predicts SCA
Cardiac Wire #255 March 16, 2025
Post-LAAO Options | Surmodics Buyout Blocked
Cardiac Wire #254 March 13, 2025
CABG or PCI for T2D Patients? | Ionis + Ono
Cardiac Wire #253 March 10, 2025
TAVR Trumps Surgery | Infant Pacemakers
Cardiac Wire #252 March 6, 2025
Independent CV Board Rejected | First Living MVR
Cardiac Wire #251 March 3, 2025
Finerenone’s Diuretic Impact | Kestra’s IPO
Cardiac Wire #250 February 27, 2025
TAVR Valve Tie | VADs for Child CHD
Cardiac Wire #249 February 24, 2025
ATTR-CM Segment Heats Up | Aspartame & Insulin
Cardiac Wire #248 February 20, 2025
Shunts Help HF? | Olpasiran vs. OxPLs
Cardiac Wire #247 February 18, 2025
Atria’s PE Alternative | SCD/MVA Genes
Cardiac Wire #246 February 13, 2025
Novartis Acquires Anthos | COVID’s Heart Risks
Cardiac Wire #245 February 10, 2025
TAVR’s Weekend Effect | SAVR/CABG Advantage
Cardiac Wire #244 February 6, 2025
Lowering Elderly LDL-C | Merck Halts HYPERION
Cardiac Wire #243 February 3, 2025
Increasing CVD Burdens | New Lp(a) Test
Cardiac Wire #242 January 30, 2025
Mechanical AVR Still Matters | Neko’s Full-Body Fundraise
Cardiac Wire #241 January 27, 2025
Abelacimab’s Stroke Uncertainty | Keros Quits TROPOS
Cardiac Wire #240 January 23, 2025
GLP-1 Side Effects | CABG Guideline Debate
Cardiac Wire #239 January 16, 2025
